Euroapi Company Header Euroapi Company Header

X

Find the latest Drugs in Development and Pipeline Prospector News of Neuramedy.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Neuramedy
korearepublicofnew Flag
Country
Country
South Korea
Address
Address
#402, 20, Gwangnaru-ro 6-gil, Seongdong-gu, Seoul
Telephone
Telephone
+82-2-765-3344
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Under the terms of the agreement, Neuramedy has obtained worldwide rights to research, develop and commercialize an xB3TM version of its antibody, Tomaralimab, directed at the Toll-like receptor 2.


Lead Product(s): Tomaralimab

Therapeutic Area: Neurology Product Name: NM-101

Highest Development Status: PreclinicalProduct Type: Large molecule

Partner/Sponsor/Collaborator: Bioasis

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration May 10, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY